Clinical Trial Update: Sodium Chloride and Contrast Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial to evaluate sodium chloride for prevention of contrast-induced nephropathy has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus
• Heart Failure
• Kidney Injury

Drugs mentioned

• Sodium chloride solution (sodium chloride solution)

Snippet

Sponsor: Hospital Universitario Ramon y Cajal | Conditions: Kidney Failure, Chronic, Kidney Failure, Acute | Phase 2 | Status: COMPLETED | Results posted: 2025-03-20